6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole

C54H56BClN12O2S2 — CID 157405485

IUPAC6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole
SMILESCC1(C)OB(c2ccc3ncsc3c2)OC1(C)C.C[C@H]1CCCN1c1cccc(Cc2cc(-c3ccc4ncsc4c3)nn3ccnc23)n1.C[C@H]1CCCN1c1cccc(Cc2cc(Cl)nn3ccnc23)n1
InChIInChI=1S/C24H22N6S.C17H18ClN5.C13H16BNO2S/c1-16-4-3-10-29(16)23-6-2-5-19(27-23)12-18-13-21(28-30-11-9-25-24(18)30)17-7-8-20-22(14-17)31-15-26-20;1-12-4-3-8-22(12)16-6-2-5-14(20-16)10-13-11-15(18)21-23-9-7-19-17(13)23;1-12(2)13(3,4)17-14(16-12)9-5-6-10-11(7-9)18-8-15-10/h2,5-9,11,13-16H,3-4,10,12H2,1H3;2,5-7,9,11-12H,3-4,8,10H2,1H3;5-8H,1-4H3/t16-;12-;/m00./s1
InChIKeyBNQZSYGBUCWEFZ-DLCSEWCFSA-N
MW1015.52 g/mol
LogP10.93
Rot. Bonds8

About 6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole

6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole (PubChem CID 157405485) has the molecular formula C54H56BClN12O2S2 and a molecular weight of 1015.52 g/mol. Its IUPAC name is 6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole.

Molecular Properties

Compound Name6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole
PubChem CID157405485
Molecular FormulaC54H56BClN12O2S2
Molecular Weight1015.52 g/mol
Exact Mass1014.39
IUPAC Name6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole
SMILESCC1(C)OB(c2ccc3ncsc3c2)OC1(C)C.C[C@H]1CCCN1c1cccc(Cc2cc(-c3ccc4ncsc4c3)nn3ccnc23)n1.C[C@H]1CCCN1c1cccc(Cc2cc(Cl)nn3ccnc23)n1
InChIInChI=1S/C24H22N6S.C17H18ClN5.C13H16BNO2S/c1-16-4-3-10-29(16)23-6-2-5-19(27-23)12-18-13-21(28-30-11-9-25-24(18)30)17-7-8-20-22(14-17)31-15-26-20;1-12-4-3-8-22(12)16-6-2-5-14(20-16)10-13-11-15(18)21-23-9-7-19-17(13)23;1-12(2)13(3,4)17-14(16-12)9-5-6-10-11(7-9)18-8-15-10/h2,5-9,11,13-16H,3-4,10,12H2,1H3;2,5-7,9,11-12H,3-4,8,10H2,1H3;5-8H,1-4H3/t16-;12-;/m00./s1
InChIKeyBNQZSYGBUCWEFZ-DLCSEWCFSA-N
XLogP10.93
TPSA136.88 Ų
H-Bond Donors
H-Bond Acceptors16
Rotatable Bonds8
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001015.52
LogP ≤ 510.93
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole?
The IUPAC name of 6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole (CID 157405485) is 6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole.
What is the SMILES notation for 6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole?
The canonical SMILES for 6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole is CC1(C)OB(c2ccc3ncsc3c2)OC1(C)C.C[C@H]1CCCN1c1cccc(Cc2cc(-c3ccc4ncsc4c3)nn3ccnc23)n1.C[C@H]1CCCN1c1cccc(Cc2cc(Cl)nn3ccnc23)n1.
What is the InChIKey of 6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole?
The InChIKey is BNQZSYGBUCWEFZ-DLCSEWCFSA-N. The full InChI is InChI=1S/C24H22N6S.C17H18ClN5.C13H16BNO2S/c1-16-4-3-10-29(16)23-6-2-5-19(27-23)12-18-13-21(28-30-11-9-25-24(18)30)17-7-8-20-22(14-17)31-15-26-20;1-12-4-3-8-22(12)16-6-2-5-14(20-16)10-13-11-15(18)21-23-9-7-19-17(13)23;1-12(2)13(3,4)17-14(16-12)9-5-6-10-11(7-9)18-8-15-10/h2,5-9,11,13-16H,3-4,10,12H2,1H3;2,5-7,9,11-12H,3-4,8,10H2,1H3;5-8H,1-4H3/t16-;12-;/m00./s1.
What are the key properties of 6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole?
6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole has a molecular weight of 1015.52 g/mol, XLogP of 10.93, 8 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 6-chloro-8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazine;6-[8-[[6-[(2S)-2-methylpyrrolidin-1-yl]-2-pyridinyl]methyl]imidazo[1,2-b]pyridazin-6-yl]-1,3-benzothiazole;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole is sourced from PubChem (CID 157405485), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).